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Abstract
Background:  The ability to transfect and create transgenic cultured malaria parasites has
transformed the study of Plasmodium falciparum over the last decade. With the completion of the
annotated genome sequence, the process of gene discovery now routinely includes gene
knockouts, over-expression and complementation analysis. However, while this technology has
proven extremely valuable, significant limitations exist. In particular, P. falciparum DNA is often
unstable and difficult to clone because of its AT-rich, repetitive nature. As a result, transgene
expression constructs can be difficult to assemble due to the need to include two expression
cassettes on a single plasmid, one to drive expression of the transgene of interest and a second for
expression of the selectable marker. In addition, transgene expression levels are usually not
regulatable, making it difficult to assess phenotypes that are sensitive to the amount of protein
expressed.
Results:  A plasmid based system for transgene expression is described that uses a single,
bidirectional promoter to drive expression of both the transgene and the selectable marker, thus
greatly reducing the size of the construct and enhancing stability. Further, by altering the
concentration of drug used for selection, it is possible to modulate the copy number of the
concatameric episomes and thereby regulate the expression level of the transgene through a range
greater than 10 fold.
Conclusion: The transgene expression system described here should prove useful for both
routine protein over-expression and complementation experiments as well as for experiments in
which precisely manipulating the expression level of candidate proteins is desirable. This should
provide an additional level of precision to the tools used to study the molecular biology of malaria
parasites.
Background
Over a decade ago, the first transfections and genetic
manipulations of malaria parasites were accomplished [1-
3], ushering in a new era in the study of the molecular
biology and biochemistry of both human and rodent par-
asites. Since then, numerous studies have been published
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utilizing transfection to both knockout various genes as
well as to over-express modified transgenes to investigate
such aspects of parasite biology as mechanisms of drug
resistance and protein trafficking[4,5]. Combined with
the release of the annotated genome sequences of numer-
ous parasite species as well as several different isolates of
Plasmodium falciparum, there have been unprecedented
recent advances in gene discovery in malaria parasites[6].
Thus the development of the current tools used to geneti-
cally manipulate parasites continues to contribute sub-
stantially to the understanding of the basic biology of
malaria.
While the ability to genetically manipulate cultured P. fal-
ciparum parasites has proven to be extremely useful, the
tools that are currently used have several limitations. For
example, all systems for transfecting cultured parasites are
based on circular plasmids that are initially created and
produced using transformed Escherichia coli. These plas-
mids are then introducing into cultured parasites. The
requirement that all constructs must first transition
through  E. coli necessitates that the parasite DNA
sequences included on the plasmids be stably replicated
by the bacteria, a property that many sequences lack due
to the extremely AT-rich, repetitive nature of the P. falci-
parum  genome, particularly in non-coding regions[7].
This difficulty is especially pronounced when trying to
over-express transgenes from episomal constructs which
require two separate cassettes, the first containing the
transgene to be expressed, the second containing the
selectable marker, and both requiring separate promoter
and terminator elements. Such constructs must, therefore,
contain several lengthy stretches of P. falciparum DNA and
stability in E. coli can be a significant issue.
A second limitation for parasite transgene expression
regards the inability to control and manipulate the expres-
sion level of the gene of interest. Currently, the level of
expression is a result of the copy number of the episomal
plasmid as well as the strength of the promoter driving
transcription of the transgene. These two parameters are
determined by the DNA sequences included in the plas-
mid and therefore can only be changed by making sub-
stantial alterations to the construct and repeating the
transfection. The ability to regulate expression levels
directly within transfected parasites would provide an
additional layer of control and allow researchers to inves-
tigate phenotypes resulting from different amounts of
expressed protein. Recently, several systems have been
described which allow the regulation of gene expression,
e.g. via Atc-inducible system[8], the use of a protein desta-
bilization domain[9] or ribozymes[10]. However, due to
the complexity of these systems their utility for wide-
spread use in malaria research remains to be proven[11].
A new system for transgene expression is described here
that addresses some of the limitations mentioned above.
By utilizing DNA sequences that contain bidirectional
promoter activity, expression constructs were created that
use a single stretch of P. falciparum intergenic sequence to
drive expression of both a transgene as well as a selectable
marker, resulting in a smaller, more stable plasmid. Sec-
ond, by using the blasticin-S-deaminase selectable marker
and altering the concentration of blasticidin used for
selection, it is possible to tightly control and manipulate
the copy number of episomes carried by the parasites. In
turn this leads to controlled levels of transgene expres-
sion, thus providing a novel manipulatable expression
system for cultured P. falciparum parasites. This system
should prove valuable for studies that employ over-
expression to determine protein function or localization,
as well as in complementation experiments used to vali-
date knockout phenotypes.
Methods
Plasmodium falciparum culture and transfection
All experiments utilized the P. falciparum NF54 line culti-
vated at 5% haematocrit in RPMI 1640 medium, 0.5%
Albumax II (Invitrogen, Carlsbad, California, United
States), 0.25% sodium bicarbonate, and 0.1 mg/ml gen-
tamicin. Parasites were incubated at 37°C in an atmos-
phere of 5% oxygen, 5% carbon dioxide, and 90%
nitrogen. Parasites were transfected by using "DNA
loaded" red blood cells as previously described[12].
Briefly, 0.2 cm electroporation cuvettes were loaded with
0.175 ml of erythrocytes and 50 μg of plasmid DNA in
incomplete cytomix solution. Electroporation conditions
were 0.31 kV and 960 mFD. For stable transfections, par-
asites were cultured in media containing either 40 ng/ml
WR99210 or the designated concentration of blasticidin.
DNA constructs
Construction of pHLIDH constructs: Plasmids pVLH and
pVLHIDH were described previously[13]. The luciferase
coding region and hrp2 3'UTR of pVLH were amplified by
PCR introducing restriction sites for PstI (5') and KpnI (3')
using the primers FflucPstI: 5'-AACTGCAGGCATGGAA-
GACGCCAAAAAC-3' and hrp3'downKpnI: 5'-GGGGTAC-
CCGCCTCTCCCCGCGCGTTGG-3'. Subsequently, this
fragment was ligated into PstI/KpnI digested pVLHIDH to
replace the VLH portion (var promoter, luciferase and hrp2
3'UTR) to yield plasmid pHLIDH. In the resulting plas-
mid, the PFB1055c intron acts as a promoter for both the
reporter and drug resistance genes. Additional intron
sequences were first amplified from genomic DNA with
the following primers, thereby adding the restriction sites
BamHI and SalI to the 5' and 3'ends, respectively, and
inserted into BamHI/SalI digested pHLIRH. Gene specific
primers for var introns: PFC0005w: 5'-CGGGATCCGAAG-
GTAAAAGAGAATATATATGTG-3'/5'-GCGTCGACT-Malaria Journal 2008, 7:86 http://www.malariajournal.com/content/7/1/86
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TCTAAAATAATAAAAGAGG-3'; PFF0845c: 5'-
CGGGATCCCTAAAGGTATTATATATG-3'/5'-GCGTC-
GACGATCAATAGTAGATTTGG-3'; PFD0020c: 5'-
CGGGATCCGCGCTTTTATTTTTGAAGG-3'/5'-GCGTC-
GACGGTCCACAGGAGATTTAGG-3'. For the construc-
tion of pHLsti/CamDH, the intron in pHLIDH (SmaI and
SalI) was replaced with the PfCam promoter from pHH-
Tati2 construct (HpaI and SalI) (gift of M. Meissner)[8].
Contruction of pHBIRH vectors: Luciferase gene was cut
out pHLIRH with HindIII and SmaI and replaced with the
blasticidin S deaminase gene obtained by restriction
digestion of pVcBB/IDH[14] with HindIII and HpaI.
Restriction sites BamHI and SalI were used to exchange
bidirectional promoters between plasmids pHLIDH,
pHLIRH and pHBIRH.
Renilla and firefly luciferase assays
Parasites were synchronized by magnetic cell separation
using MACS CS columns (Miltenyi Biotech) and con-
firmed by light microscopy. Parasitaemias were counted
for 1000 RBCs. For luciferase assays, parasites were
obtained from 200 μl of culture by centrifugation and
subsequent lysis in 100 μl of Glo Lysis Buffer (Promega).
To determine firefly luciferase expression, 100 μl of
Bright-Glo Luciferase reagent was added to the lysate and
luminescence was measured immediately in a TD-20/20
luminometer. For Renilla  luciferase expression, 100 μl
Renilla assay reagent (Promega) was added to the lysate
and luminescence determined using the TD-20/20 lumi-
nometer. For both Renilla and firefly luciferase, lumines-
cence was expressed per 1% parasitaemia.
Quantitative Realtime PCR assays
RNA was extracted from synchronized ring stage parasites
16–18 h or late trophozoites 40–42 h post-invasion. RNA
extraction was performed with the TRIZOL LS Reagent
(Invitrogen) as previously described[15]. RNA to be used
for cDNA synthesis was purified on PureLink column
(Invitrogen) according to manufacturer's protocol. Iso-
lated RNA was then treated with Deoxyribonuclease I
(Invitrogen) to degrade contaminating gDNA. cDNA syn-
thesis was performed with Superscript II Rnase H reverse
transcriptase (Invitrogen) as described by the manufac-
turer. cDNA was synthesized from 800 ng total RNA in a
reaction volume of 20 μl. For each cDNA synthesis reac-
tion, a control reaction without reverse transcriptase was
performed with identical amounts of template and prim-
ers. Realtime PCR was carried out as described previ-
ously[14]. All reactions were performed at a final primer
concentration of 0.5 μM using Bio-Rad ITAQ SYBR
SUPERMIX® in 20 μl reactions on an ABI Prism® 7900HT
real-time PCR machine.
All reactions included primers for the control genes seryl-
tRNA synthetase (PF07_0073), fructose biphosphate
aldolase (PF14_0425) and actin (PFL2215w), as
described by Salanti et al[16], as well as arginyl-tRNA syn-
thetase (PFL0900c) and glutaminyl-tRNA synthetase
(PF13_0170), as described by Dzikowski et al[14]. The
ΔCT for each individual primer pair was determined by
substracting the individual CT value from the CT value of
the control the seryl-tRNA synthetase. ΔCTs were then con-
verted to relative copy numbers with the formula 2ΔCt.
Primers for luciferase[17] and blasticidin[14] were previ-
ously described. Additional gene-specific primer pairs
were designed using primer 3 software[18]: Renilla luci-
ferase: 5'-TTCGAAAGTTTATGATCCAG-3'/5'-AACAT-
GTCGCCATAAATAAG-3'
msp1: 5'-TACAAGTCCATCATCTCGTT-3'/5'-TGGTTAAAT-
CAAAGAGTTCG-3'
kahrp: 5'-CAATTACAACCTCAACAACC-3'/5'-TTTTAC-
CATCGACAACATTT-3'
sbp1: 5'-AATCCACAACTGATTTGGTA-3'/5'-GAATAG-
GGGACATAGATTCG-3'.
Results
Episomal expression of luciferase and dhfr in stably 
transformed parasites
In an attempt to create smaller, more stable expression
constructs for transfecting cultured P. falciparum parasites,
plasmids were constructed that contained both the dhfr
and luciferase coding regions arranged such that expres-
sion of both genes was driven simultaneously from a sin-
gle bidirectional promoter (Figure 1A). Three different
promoters were compared: two var  introns from genes
PFB1055c and PFC0005w, respectively, and the 5'
upstream region of the Pfcam gene. The promoter activity
of var introns has been previously documented[13], and
the ~1 kb region upstream of Pfcam had been previously
shown to have bidirectional promoter activity[3]. In a
more detailed analysis[19] it was shown that this
sequence is located between two genes in head-to-head
orientation and contains two different promoters, one for
the Pfcam gene and a second one in the reverse orientation
for an open reading frame that shows homology to stress-
inducible genes in yeast and hence has been named P. fal-
ciparum stress-inducible gene (Pfsti). P. falciparum para-
sites were transfected with all three constructs and, after
selection with WR99210, stably transformed parasite lines
were obtained with each of the constructs, indicating the
dhfr gene was expressed at sufficient levels to readily pro-
duce drug resistant parasites.
To determine the efficiency of transgene expression from
the different constructs, the three parasite lines were syn-Malaria Journal 2008, 7:86 http://www.malariajournal.com/content/7/1/86
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Episomal expression of luciferase with constructs utilizing bidirectional promoters Figure 1
Episomal expression of luciferase with constructs utilizing bidirectional promoters. A: Diagram of bidirectional 
constructs: introns of var genes PFB1055c and PFC0005w are shown in the top diagram while the 5' regions of calmodulin gene 
(Pcam) and the stress-inducible gene (Psti) are shown on the bottom. firefly refers to the firefly luciferase gene. 3'denotes the 
3'untranslated region of the Pfhrp2 gene. The total construct lengths are 7162 bp, 7254 bp and 7315 bp for plasmids containing 
the PFB1055c, PFC0005w and Pcam/Psti promoters, respectively. B: P. falciparum NF54 stably transformed with bidirectional 
constructs containing var intron PFB1055c (gray), var intron PFC0005w (black) and Psti/Pcam (white) promoters were synchro-
nized by magnetic cell separation and luciferase activity was measured at different time points throughout the asexual cycle. 
Samples were measured in triplicates and error bars indicate the standard deviation. C: mRNA levels were determined by syn-
thesis of cDNA followed by quantitative realtime PCR analysis. RNA levels of dhfr (dark gray) and luciferase (hatched) were 
compared to P. falciparum genes sbp1 (black) and msp1 (white). RNA was extracted ~16 h (ring) and 40 h (schizont) post-inva-
sion.
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chronized and luciferase and dhfr expression were analysed
at different stages of the intraerythrocytic cell cycle (Figure
1). The construct with var intron PFC0005w produced the
highest level of luciferase expression, although all three
transformed lines were well above background. luciferase
expression of all three parasite lines was significantly
higher in late stages than in ring stages (Figure 1B). For the
two intron promoters this was expected and corresponds
to the previously reported activity of var intron promoters
and synthesis of non-coding var RNAs[20]. The Psti/cam
promoter is active in a more constitutive manner and
shows a lower degree of stage specificity. Compared to var
intron PFB1055c, the Psti/cam promoter becomes active
earlier in the cell cycle with luciferase levels ~10 fold
higher in ring stage. Its activity shows a slower increase
over the course of the cell cycle to finally achieve maxi-
mum expression in schizonts with luciferase activity sim-
ilar to that produced by the construct with the PFB1055c
var intron.
To quantitatively analyse expression of the dhfr gene in
the transfected lines, realtime RT-PCR was used to meas-
ure steady state mRNA levels. This analysis showed that
dhfr and luciferase expression correlated in all constructs,
consistently showing stronger expression in late stages
(Figure 1C). This indicates that the promoter activities in
the forward and reverse orientations are not regulated
independently, but are strictly linked. This is particularly
interesting for the promoter region of Psti/cam as it con-
tains two promoters for different genes that might have
been expected to be regulated separately. It has been
hypothesized that the Psti  upstream regulatory region
does not contain a constitutive promoter, but rather
might be inducible only in response to cellular stress[19].
An induction of Psti promoter activity was not observed
under temperature stress (data not shown) and it is
assumed that the promoter activity measured in this assay
corresponds to the "normal" promoter activity of the Psti
gene. However, the possibility that the Psti promoter is
inducible under different conditions and that in this assay
a low "stand-by" activity was measured cannot be
excluded.
Transcription levels of luciferase and dhfr were compared
to two single copy P. falciparum genes, skeleton binding
protein 1 (sbp1) and merozoite surface protein 1 (msp1).
The sbp1 gene is expressed early in the cell cycle, therefore,
sbp1 RNA levels in ring stages are much higher than for
luciferase, while in late stages, sbp1 expression is low com-
pared to luciferase. Thus the expression of luciferase and
sbp1 are inversely correlated. As a consequence the expres-
sion constructs described here would not be expected to
be suitable for the expression of ring-specific genes. In
contrast, msp1 is expressed later in the cell cycle. Although
msp1 transcription is not exclusively restricted to tropho-
zoites, but starts already in late ring stages, msp1 expres-
sion increases over the course of the cell cycle and RNA
levels peak in late trophozoites[21,22]. Due to the late-
stage specific activity of the intron promoters, the expres-
sion pattern of luciferase corresponds more closely to that
of msp-1. In schizont stage the expression levels of luci-
ferase produced by the construct with the stronger intron
promoter (var  PFC0005w) are very similar to those of
msp1. Therefore, the pHLIDH constructs might be suitable
vectors for the expression of late stage genes such as msp1.
Episomal co-expression of luciferase and blasticidin-S-
deaminase in stably transformed parasites
In stably transformed P. falciparum parasites, episomes are
usually present as concatemers[23,24]. This potentially
enhances the expression of the resistance marker by pro-
viding transfected parasites with multiple copies of the
resistance gene. It had previously been observed that epi-
some copy number can vary when blasticidin-S-deami-
nase (bsd) was used as a selection marker, showing a direct
correlation of drug concentration and the number of plas-
mid copies. In the expression constructs described here
containing bidirectional var  introns, expression of the
resistance and reporter genes were strictly linked. It was
therefore hypothesized that it might be possible to regu-
late expression levels of a reporter gene (or a transgene of
interest) by varying blasticidin concentration in the cul-
ture media. For this purpose, constructs were made that
contained bsd as a resistance marker and Renilla luciferase
(pHBIRH) as reporter gene, both simultaneously
expressed from a bidirectional promoter. Two different
var introns, PFC0005w and PFD0020c, were used as pro-
moters (Figure 2). These constructs were used to stably
transform  P. falciparum NF54 parasites using selection
with 2 μg/ml blasticidin. Both parasite lines displayed the
expected stage-specific expression pattern, with approxi-
mately five-fold higher Renilla  luciferase expression in
schizonts than in rings. pHBIRH with the PFC0005w
intron produced much stronger Renilla luciferase expres-
sion than did the intron from PFD0020c. Therefore,
pHBIRH containing var intron PFC0005w was used for
further experiments.
Regulation of Renilla luciferase expression by altering 
blasticidin concentration
P. falciparum parasites stably carrying pHBIRH (intron
PFC0005w) were divided into identical cultures and
grown in the presence of 2, 5, 10 and 20 μg/ml blasticidin
for four weeks. In the cultures containing 10 and 20 μg/ml
blasticidin, dead parasites were detected initially and
growth of the cultures slowed down significantly. How-
ever, after five cycles (10 μg/ml) or eight to 10 cycles (20
μg/ml), cultures had recovered and parasite growth
resumed at usual rates. All four cultures were synchro-
nized and Renilla luciferase activity was measured at theMalaria Journal 2008, 7:86 http://www.malariajournal.com/content/7/1/86
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ring stage (~16 h post invasion) and trophozoite stage
(~40 h post invasion). As expected, Renilla  luciferase
expression was stage-specific with ~five-fold greater activ-
ity in trophozoites (Figure 3A). In both stages, a linear cor-
relation of Renilla  luciferase activity and blasticidin
concentration was observed, demonstrating that regula-
tion of an episomally expressed reporter gene is possible
by varying the concentration of the drug used for selec-
tion.
To investigate if the increase in Renilla luciferase expres-
sion resulted from an increase in promoter activity or
rather reflected an increase in the copy number of the
expression construct, DNA was extracted from the differ-
ent parasite lines and the copy numbers of the bsd and
Renilla luciferase genes were determined by quantitative
PCR and compared to several single-copy genes of P. falci-
parum. There was a 10 to 20-fold difference in copy num-
bers between cultures grown in the presence of 2 μg/ml
and 20 μg/ml blasticidin. In all four cultures, the copy
numbers of the expression constructs displayed a linear
correlation with both blasticidin concentration and
Renilla luciferase activity (Figure 3B), indicating that the
increase in bsd and Renilla luciferase expression was not
due to changes in promoter activity but rather to a change
in copy number of the expression construct. Thus the plas-
mid copy number can be regulated over a 10-fold range by
altering the drug concentration used for selection and in
this way the expression of the transgene (in this case
Renilla luciferase) can be co-regulated. Episomal plasmids
are usually present as concatemeres of up to 15 cop-
ies[23,24] suggesting that changes in concatemer size are
the most likely mechanism for copy number variation,
however, it is also possible that an increase in copy
number is caused by presence of multiple episomes per
parasite.
Manipulating episome copy number to "fine-tune" 
transgene expression levels
A possible application of these constructs could be the
expression of a gene of interest in place of Renilla luciferase
to investigate its putative biological function. As the effect
of over-expressing genes in Plasmodium depends on the
timing and the strength of expression[25], the expression
levels of Renilla luciferase and bsd were compared to the
expression levels of several endogenous P. falciparum
genes. cDNA was prepared from trophozoites and subse-
quently analysed by quantitative PCR. As expression from
intron promoters is restricted to late stages, we compared
the expression levels to that of msp1, a gene that is simi-
larly primarily expressed in late stages. The relative
amount of bsd and Renilla luciferase RNA directly corre-
lated with blasticidin concentration, corroborating the
results of the Renilla luciferase activity measurement (Fig-
ure 3C). RNA levels of Renilla luciferase were lower than
msp1  for blasticidin concentrations of 2 and 5 μg/ml,
however parasites growing in the presence of 10 μg/ml
showed nearly equal expression levels of Renilla luciferase
and msp-1 (Renilla luciferase 92% of msp1). In parasites
growing in the presence of 20 μg/ml, Renilla luciferase RNA
levels were ~40% higher than msp1 RNA. Other genes that
are ring-stage specific (kahrp and sbp1) were expressed at
lower levels in late trophozoites and served as controls.
These results show that with the novel expression con-
structs described here, gene expression can be regulated
over an approximately 10-fold range and, as was exempli-
fied with msp1, expression levels can be achieved that cor-
respond to endogenous transcription levels. In addition,
the effect of a co-expressed gene (or a truncated version
thereof) can be analysed by choosing concentrations that
result in mRNA amounts above or below the "normal"
expression level.
Cell cycle dependent episomal expression of Renilla luciferase  from HBIRH with two different var intron promoters Figure 2
Cell cycle dependent episomal expression of Renilla 
luciferase from HBIRH with two different var intron 
promoters. A: Diagram of bidirectional expression con-
struct pHBIRH. The construct contains the intron from 
either PFC0005w or PFD0020c, resulting in total plasmid 
sizes of 6380 bp or 6432 bp, respectively. bsd: blasticidin-S-
deaminase gene; 3': 3'untranslated region of Pfhrp2; Renilla: 
Renilla luciferase gene; intron: intron var gene containing bi-
directional promoter activity. B: Luciferase activity was meas-
ured from P. falciparum NF54 parasites stably transformed 
with pHBIRH containing either var intron PFC0005w (grey) 
or var intron PFD0020c (black) as a bidirectional promoter. 
Samples were taken at different time points throughout 
intra-eryhtrocytic cycle: 16 h (ring), 32 h (troph) and 40 
hours (schizont) post-invasion. Samples were measured in 
triplicate and error bars indicate the standard deviation.
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Discussion
The regulatable expression system described here appears
to rely on the flexibility in copy number of episomal plas-
mid concatamers. It, therefore, seems unlikely that this
system will work with constructs that have integrated into
the parasite's genome. It is probably best that experiments
in which alterations in transgene expression are desired be
performed on parasites shortly after stably transformed
lines have been obtained in order to avoid the chromo-
somal integrations that are typical after long-term culture
of transfected parasites. In addition, the plasmid con-
structs described here all utilize bidirectional promoters
that are primarily active late in the cell cycle. In theory,
similar plasmids could be constructed that utilize a ring
stage specific promoter and thus allow regulated expres-
sion early in the cell cycle. A similar system was previously
described that utilized the constitutively active bi-direc-
tional promoter of the ef-1α gene of Plasmodium berghei,
which might provide expression through a broader range
of the parasite cell cycle[26].
The blasticidin resistance gene is the ideal selectable
marker for the type of manipulatable system described
here. Unlike the dhfr selectable markers, which encode
proteins that are resistant to the drug used for selection,
bsd instead encodes a protein that inactivates blasticidin.
Regulated expression of Renilla luciferase using variable blasticidin selection Figure 3
Regulated expression of Renilla luciferase using variable blasticidin selection. P. falciparum NF54 parasites stably 
transformed with pHBIRH containing var intron PFC0005w were grown in presence of different blasticidin concentrations; 2 
μg/ml (black), 5 μg/ml (dark grey), 10 μg/ml (light grey) and 20 μg/ml (white). A: Renilla luciferase activity measured 16–18 h 
(ring) and 40–42 h (late troph) after invasion. B: DNA was extracted from parasite cultures and the copy numbers of blasticidin 
(bsd), Renilla luciferase (ren) and the Plasmodium genes kahrp, sbp1 and msp1 were determined by quantitative realtime PCR. Val-
ues were standardized to the control gene seryl-tRNA synthetase. Samples were measured in triplicate and error bars indicate 
the standard deviation. C: mRNA levels were determined by quantitative realtime PCR analysis of cDNA. RNA was extracted 
from synchronized parasite cultures in the late trophozoite stage. ct values were standardized to control gene seryl-tRNA syn-
thetase and relative mRNA copy numbers are displayed as percentile of msp1 (100%).
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Thus, the addition of increasing amounts of blasticidin
requires corresponding increases in blasticidin-S-deami-
nase encoded by bsd in order to detoxify the compound
and maintain parasite viability. By driving expression of
the transgene of interest with the same promoter that
drives bsd expression, increased bsd expression necessitates
increased transgene expression, giving the regulatable
expression that is desired. Removal of blasticidin from the
media results in rapid loss of the transfecting plasmid
(data not shown), suggesting that transgene expression
levels can be lowered by reducing blasticidin selection
pressure. In addition, since blasticidin is not an anti-
malaria drug commonly used in the field, all parasite iso-
lates typically used for molecular genetic studies are sensi-
tive to this drug, and therefore the constructs described
here should work in all of these laboratory lines. It is not
clear if this type of system will work with rodent parasites
like Plasmodium berghei. These parasites must be reared in
their mammalian hosts, and the effect of blasticidin on
host viability has prevented it from being developed as a
selection tool for generating transgenic parasites in these
systems. The development of new selectable markers for
rodent parasites might negate this problem and allow a
similar expression system to be developed.
Other systems have been described recently that allow the
conditional activation of a transgene[11], however these
systems are more complex and hence more difficult to
establish. For instance, the Atc-regulatable system[8]
requires two different components that either need to be
inserted in two different selection cycles or are provided
on one very large construct. The utility of the FKBP12 sys-
tem[9] is dependent on the confirmation of the protein of
interest fused to the protein destabilization domain and
the efficacy of the system might vary largely between dif-
ferent proteins investigated. The system described here is
not an inducible system and there is no possibility to
switch it off completely. It rather provides the possibility
to adjust the level of gene expression by selection for
transgene copy number. Therefore, gene regulation is not
possible within hours but, depending on the desired
expression level, up to 2–3 weeks of selection are needed.
The significant advantage is the simplicity and hence sta-
bility of the bidirectional constructs. Manipulation by
DNA cloning is relatively easy and the initial generation of
stable transformants is straightforward. During cloning of
the several constructs described here not a single deletion
or truncation event was observed. While the use of the
same 3' UTR sequence for both transgenes could poten-
tially lead to deletion of the intervening sequence during
propagation in E. coli, such deletions were never detected
in any of our small or large scale plasmid DNA prepara-
tions, suggesting that the constructs are quite stable. In
addition, the identical 3'UTR sequences are oriented in
opposite directions and therefore homologous recombi-
nation would be expected to produce an inversion of the
entire expression cassette rather than a deletion.
Conclusion
The ability to genetically manipulate cultured malaria par-
asites has made a tremendous impact on the understand-
ing of the molecular biology of these organisms. As
knowledge of these pathogens becomes more advanced,
the ability to perform more precisely regulated experi-
ments will be needed. By using the adjustable transgene
expression system described here, it should be possible to
control the expression level of a gene of interest, thus
allowing a researcher to determine the effect of normal
expression, under-expression or over-expression on para-
site growth, metabolism or viability. This type of "fine-
tuning" of expression levels will be particularly important
for the study of protein localization, where mis-timing or
over-expression can lead to incorrect localization of a pro-
tein. Similarly, manipulating the level of transgene expres-
sion can be useful in complementation studies where the
chromosomal copy of a gene has been knocked out, or in
cases where expression of a dominant negative version of
a protein requires particularly high expression levels to
cause a phenotype. For dominant negatives, the expres-
sion level of the transgene could potentially be adjusted to
a level that displays a phenotype but remains sub-lethal.
The ability to control transgene expression therefore has
added an additional tool to the repertoire of molecular
techniques and provides a relatively simple and robust
alternative for the specific analysis of gene function in
Plasmodium falciparum.
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